The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome
Primary Purpose
Hypercholesterolaemia
Status
Completed
Phase
Phase 4
Locations
Belgium
Study Type
Interventional
Intervention
commercially available nutrition supplement
placebo
Sponsored by
About this trial
This is an interventional treatment trial for Hypercholesterolaemia
Eligibility Criteria
Inclusion Criteria:
metabolic syndrome according to ATPIII criteria 3 of the following:
- waist circumference >88cm (in females) or >102cm (in males)
- triglycerides >150mg/dl
- HDL <40 (50)mg/dl in males (females)
- blood pressure>130/85 or treatment for AHT
- glucose >110mg/dl
Exclusion Criteria:
- pregnancy
- treatment with cholesterol lowering drugs
Sites / Locations
- University of Antwerp
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
commercially available nutrition supplement
control group
Arm Description
this group receives a commercially available nutritional supplement for a period of 2 months
this group receives a placebo for a period of 2 months
Outcomes
Primary Outcome Measures
LDL level
total cholesterol level
triglyceride level
HDL level
Secondary Outcome Measures
OxLDL
BMI
malondialdehyde (MDA)
8-OH-deoxyguanosine (8-OHdG)
side effects
waist circumference
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02065180
Brief Title
The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome
Official Title
The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol
Study Type
Interventional
2. Study Status
Record Verification Date
May 2014
Overall Recruitment Status
Completed
Study Start Date
February 2014 (undefined)
Primary Completion Date
May 2014 (Actual)
Study Completion Date
May 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Universiteit Antwerpen
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
This randomised controlled trial studies the effect of a commercially available nutritional supplement on cholesterol levels in people with metabolic syndrome and elevated cholesterol levels.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypercholesterolaemia
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
50 (Actual)
8. Arms, Groups, and Interventions
Arm Title
commercially available nutrition supplement
Arm Type
Experimental
Arm Description
this group receives a commercially available nutritional supplement for a period of 2 months
Arm Title
control group
Arm Type
Placebo Comparator
Arm Description
this group receives a placebo for a period of 2 months
Intervention Type
Dietary Supplement
Intervention Name(s)
commercially available nutrition supplement
Intervention Description
the food supplement contains red rice yeast and olive extract
Intervention Type
Dietary Supplement
Intervention Name(s)
placebo
Primary Outcome Measure Information:
Title
LDL level
Time Frame
2 months
Title
total cholesterol level
Time Frame
2 months
Title
triglyceride level
Time Frame
2 months
Title
HDL level
Time Frame
2 months
Secondary Outcome Measure Information:
Title
OxLDL
Time Frame
2 months
Title
BMI
Time Frame
2 months
Title
malondialdehyde (MDA)
Time Frame
2 months
Title
8-OH-deoxyguanosine (8-OHdG)
Time Frame
2 months
Title
side effects
Time Frame
2 months
Title
waist circumference
Time Frame
2 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
metabolic syndrome according to ATPIII criteria 3 of the following:
waist circumference >88cm (in females) or >102cm (in males)
triglycerides >150mg/dl
HDL <40 (50)mg/dl in males (females)
blood pressure>130/85 or treatment for AHT
glucose >110mg/dl
Exclusion Criteria:
pregnancy
treatment with cholesterol lowering drugs
Facility Information:
Facility Name
University of Antwerp
City
Antwerp
State/Province
Belgie
ZIP/Postal Code
2610
Country
Belgium
12. IPD Sharing Statement
Citations:
PubMed Identifier
28673363
Citation
Hermans N, Van der Auwera A, Breynaert A, Verlaet A, De Bruyne T, Van Gaal L, Pieters L, Verhoeven V. A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA2, in subjects with metabolic syndrome: a randomised, double-blind, placebo-controlled trial. Trials. 2017 Jul 3;18(1):302. doi: 10.1186/s13063-017-2058-5.
Results Reference
derived
PubMed Identifier
25879228
Citation
Verhoeven V, Van der Auwera A, Van Gaal L, Remmen R, Apers S, Stalpaert M, Wens J, Hermans N. Can red yeast rice and olive extract improve lipid profile and cardiovascular risk in metabolic syndrome?: A double blind, placebo controlled randomized trial. BMC Complement Altern Med. 2015 Mar 10;15:52. doi: 10.1186/s12906-015-0576-9.
Results Reference
derived
Learn more about this trial
The Effect of a Red Rice and Olive Extract Nutrition Supplement on Cholesterol Levels in Patients With Metabolic Syndrome
We'll reach out to this number within 24 hrs